hailshadow-istockphoto-com

Hailshadow / iStockphoto.com

14 June 2018Americas

PTAB rejects IPR challenges to Gilead patents

The Patent Trial and Appeal Board (PTAB) has now rejected challenges to six patents owned by Gilead covering the company’s hepatitis C medicines.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

PTAB blocks Qiagen’s bid to invalidate diagnostics patent

20 July 2020 Biotechnology company Qiagen has failed in its bid to stop diagnostics company HandyLab from retaining a patent for a diagnostic system, according to a decision issued by the US Patent Trial and Appeal Board on Tuesday, July 14.

PTAB shoots down tenth I-MAK Gilead challenge

24 July 2018 The Patent Trial and Appeal Board has rejected another challenge to a Gilead-owned patent covering the company’s hepatitis C medicines.

MSF challenges Gilead patent in China

20 June 2018 Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.

More on this story

Biotechnology

PTAB blocks Qiagen’s bid to invalidate diagnostics patent

20 July 2020 Biotechnology company Qiagen has failed in its bid to stop diagnostics company HandyLab from retaining a patent for a diagnostic system, according to a decision issued by the US Patent Trial and Appeal Board on Tuesday, July 14.

PTAB shoots down tenth I-MAK Gilead challenge

24 July 2018 The Patent Trial and Appeal Board has rejected another challenge to a Gilead-owned patent covering the company’s hepatitis C medicines.

MSF challenges Gilead patent in China

20 June 2018 Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.

More on this story

Biotechnology

PTAB blocks Qiagen’s bid to invalidate diagnostics patent

20 July 2020 Biotechnology company Qiagen has failed in its bid to stop diagnostics company HandyLab from retaining a patent for a diagnostic system, according to a decision issued by the US Patent Trial and Appeal Board on Tuesday, July 14.

PTAB shoots down tenth I-MAK Gilead challenge

24 July 2018 The Patent Trial and Appeal Board has rejected another challenge to a Gilead-owned patent covering the company’s hepatitis C medicines.

MSF challenges Gilead patent in China

20 June 2018 Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?